NCT01672372

Brief Summary

The proposed study is a 60-day, randomized, double-blind, placebo-controlled trial to evaluate the efficacy of a methylated vitamin B complex nutritional supplement (Max Stress B™) for improving depressive and anxiety symptoms according to the Beck Depression and Anxiety Inventories, respectively, in 60 patients (18+ years of age) diagnosed with major depression or other forms of depressive disorders and an elevated level of homocysteine (\> 10 µmol/L) at baseline. Secondary outcomes will include anthropometrics for body composition, blood pressure and pulse, level of physical activity, dietary intake, and quality of life. Participants will be assessed at baseline and 30 and 60 days. The study will consist of two treatment arms: (a) vitamin B complex nutritional supplement and (b) placebo. The information obtained in this study will help in determining the efficacy of using nutritional supplements for improving the outcomes of people with depression.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable depression

Timeline
Completed

Started Jan 2011

Shorter than P25 for not_applicable depression

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2011

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

August 21, 2012

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 24, 2012

Completed
Last Updated

August 6, 2014

Status Verified

August 1, 2014

Enrollment Period

9 months

First QC Date

August 21, 2012

Last Update Submit

August 4, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Depression level

    Assessed by the Beck Depression Inventory II, the Beck Anxiety Inventory, SF-36v2™ Health Survey, physiological and anthropometric measures Because item 9 of the Beck Depression Inventory inquires about "Suicidal thoughts or wishes," we will immediately notify the attending physician in the Crisis facility of UM/JMH if a subject responds affirmatively to this question, which may be indicative of suicidal ideation (SI).

    2 months

Study Arms (2)

Placebo Max Stress B

PLACEBO COMPARATOR

oil/water emulsion with food coloring to simulate actual product

Dietary Supplement: Placebo Max Stress B

Max Stress B

EXPERIMENTAL

whole-nutrient natural source extract from probiotic colonies that contains vitamins B1, B2, B5, B6, B12, and folate, PABA, biotin, inositol, purified water and certified organic alcohol.

Dietary Supplement: Max Stress B

Interventions

Max Stress BDIETARY_SUPPLEMENT

Participants are to mix one vial per day of either placebo or actual supplement in 1 liter of water and drink over the course of the day

Max Stress B
Placebo Max Stress BDIETARY_SUPPLEMENT
Placebo Max Stress B

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women ages 18 years and over.
  • Individuals with a diagnosed type or form of depression.
  • An elevated level of homocysteine (\> 10 µmol/L) at screening.
  • Interest in participating in a novel nutritional supplement program.
  • Willingness to follow recommendations, including going off of all medication for depression 2 weeks before starting vitamin B complex regimen.

You may not qualify if:

  • Excluded in any of the above criteria are not met.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Miami CRB

Miami, Florida, 33136, United States

Location

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Officials

  • John E Lewis, PhD

    University of Miami

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 21, 2012

First Posted

August 24, 2012

Study Start

January 1, 2011

Primary Completion

October 1, 2011

Study Completion

October 1, 2011

Last Updated

August 6, 2014

Record last verified: 2014-08

Locations